All In Biotech

Free tool

FAERS Monitor: Sodium Acetate

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 018893 or its brand name (Sodium Acetate, Sodium Acetate). Reports on generic versions are filed under their own applications.

Reports

285

Serious

229

80% of reports

Hospitalization

134

Death reported

56

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use29
  • pyrexia23
  • nausea18
  • diarrhoea17
  • dyspnoea16
  • pneumonia16
  • vomiting16
  • death15
  • anaemia14
  • condition aggravated13
  • drug intolerance13
  • fatigue13
  • general physical health deterioration13
  • asthenia12
  • no adverse event12

Reports by year received

View as table
YearReports
20041
200512
20062
20073
20088
20092
20104
20116
20126
201314
20147
201511
20169
201714
201823
201926
202011
202125
202220
202314
202433
202515
202619

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,874 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
drug intoleranceSignal139.95.896
general physical health deteriorationSignal138.34.977
anaemiaSignal145.43.347
pyrexiaSignal234.93.369
no adverse eventSignal124.92.834
pneumoniaSignal163.62.329
condition aggravatedSignal133.21.917
vomitingSignal162.51.613
off label useSignal292.41.724
astheniaSignal122.41.48
dyspnoeaSignal162.11.38
diarrhoea171.91.27
nausea181.71.14
death151.30.81
fatigue131.20.70

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.